Impact of Anaemia and Dysregulated Iron Metabolism on COVID-19 Clinical Outcome – Review Article

Coronavirus disease-19 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can manifest in a wide range of forms, but the most common symptoms are fever, headache, fatigue, respiratory problems, lost sense of smell and taste, sore throat, muscle pain a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matea Bogović, Robert Rončević, Stjepan Grga Milanković
Formato: article
Lenguaje:EN
Publicado: Faculty of Medicine Osijek 2021
Materias:
R
Acceso en línea:http://dx.doi.org/10.26332/seemedj.v5i2.211
https://doaj.org/article/199a230b9af64875813f2545ae39b6e3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:199a230b9af64875813f2545ae39b6e3
record_format dspace
spelling oai:doaj.org-article:199a230b9af64875813f2545ae39b6e32021-11-29T13:45:50ZImpact of Anaemia and Dysregulated Iron Metabolism on COVID-19 Clinical Outcome – Review Articlehttp://dx.doi.org/10.26332/seemedj.v5i2.2112459-9484https://doaj.org/article/199a230b9af64875813f2545ae39b6e32021-11-01T00:00:00Zhttp://seemedj.mefos.unios.hr/index.php/seemedj/article/view/211/116https://doaj.org/toc/2459-9484Coronavirus disease-19 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can manifest in a wide range of forms, but the most common symptoms are fever, headache, fatigue, respiratory problems, lost sense of smell and taste, sore throat, muscle pain and malaise. In patients with COVID-19, the inflammatory response of the organism affects iron homeostasis. Severe COVID-19 infections may lead to a hyperinflammatory condition, characterised by elevated ferritin levels that correlate with the severity of the clinical course, prolonged intensive care unit (ICU) stay, development of acute respiratory distress syndrome and a fatal outcome. As a result of iron metabolism disorders in inflammation, decreased erythropoiesis and reduced biological activity of erythropoietin, the erythrocyte half-life is shortened, leading to anaemia of chronic inflammation. Cytokine IL-6 plays the most crucial role in regulating iron concentration. It affects iron metabolism by producing hepcidin via STAT 3. Hepcidin produces regulatory effects on iron by binding with ferroportin, the only known transmembrane iron exporter. Anaemia has long been characterised as a significant risk factor contributing to increased mortality and poorer clinical outcomes for various infections. The most severe forms of COVID-19 infection result in pneumonia, causing a reduced supply of oxygen to the circulation, ultimately leading to ischemia of vital organs. Anaemia of chronic disease is more common in COVID-19 positive patients and is associated with a poorer clinical outcome. A higher ferritin/transferrin ratio indicates an advanced inflammatory condition and may be a predictive factor of ICU admission.Matea BogovićRobert RončevićStjepan Grga MilankovićFaculty of Medicine Osijekarticlecovid-19anaemiairon metabolismsars cov-2MedicineRENSoutheastern European Medical Journal, Vol 5, Iss 2, Pp 9-17 (2021)
institution DOAJ
collection DOAJ
language EN
topic covid-19
anaemia
iron metabolism
sars cov-2
Medicine
R
spellingShingle covid-19
anaemia
iron metabolism
sars cov-2
Medicine
R
Matea Bogović
Robert Rončević
Stjepan Grga Milanković
Impact of Anaemia and Dysregulated Iron Metabolism on COVID-19 Clinical Outcome – Review Article
description Coronavirus disease-19 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can manifest in a wide range of forms, but the most common symptoms are fever, headache, fatigue, respiratory problems, lost sense of smell and taste, sore throat, muscle pain and malaise. In patients with COVID-19, the inflammatory response of the organism affects iron homeostasis. Severe COVID-19 infections may lead to a hyperinflammatory condition, characterised by elevated ferritin levels that correlate with the severity of the clinical course, prolonged intensive care unit (ICU) stay, development of acute respiratory distress syndrome and a fatal outcome. As a result of iron metabolism disorders in inflammation, decreased erythropoiesis and reduced biological activity of erythropoietin, the erythrocyte half-life is shortened, leading to anaemia of chronic inflammation. Cytokine IL-6 plays the most crucial role in regulating iron concentration. It affects iron metabolism by producing hepcidin via STAT 3. Hepcidin produces regulatory effects on iron by binding with ferroportin, the only known transmembrane iron exporter. Anaemia has long been characterised as a significant risk factor contributing to increased mortality and poorer clinical outcomes for various infections. The most severe forms of COVID-19 infection result in pneumonia, causing a reduced supply of oxygen to the circulation, ultimately leading to ischemia of vital organs. Anaemia of chronic disease is more common in COVID-19 positive patients and is associated with a poorer clinical outcome. A higher ferritin/transferrin ratio indicates an advanced inflammatory condition and may be a predictive factor of ICU admission.
format article
author Matea Bogović
Robert Rončević
Stjepan Grga Milanković
author_facet Matea Bogović
Robert Rončević
Stjepan Grga Milanković
author_sort Matea Bogović
title Impact of Anaemia and Dysregulated Iron Metabolism on COVID-19 Clinical Outcome – Review Article
title_short Impact of Anaemia and Dysregulated Iron Metabolism on COVID-19 Clinical Outcome – Review Article
title_full Impact of Anaemia and Dysregulated Iron Metabolism on COVID-19 Clinical Outcome – Review Article
title_fullStr Impact of Anaemia and Dysregulated Iron Metabolism on COVID-19 Clinical Outcome – Review Article
title_full_unstemmed Impact of Anaemia and Dysregulated Iron Metabolism on COVID-19 Clinical Outcome – Review Article
title_sort impact of anaemia and dysregulated iron metabolism on covid-19 clinical outcome – review article
publisher Faculty of Medicine Osijek
publishDate 2021
url http://dx.doi.org/10.26332/seemedj.v5i2.211
https://doaj.org/article/199a230b9af64875813f2545ae39b6e3
work_keys_str_mv AT mateabogovic impactofanaemiaanddysregulatedironmetabolismoncovid19clinicaloutcomereviewarticle
AT robertroncevic impactofanaemiaanddysregulatedironmetabolismoncovid19clinicaloutcomereviewarticle
AT stjepangrgamilankovic impactofanaemiaanddysregulatedironmetabolismoncovid19clinicaloutcomereviewarticle
_version_ 1718407330498871296